February Pharmacy UpdateFebruary 1st, 2018 | Clinical Connections•News
We have begun efforts to design and initiate an outpatient Pharmacy & Therapeutics (P&T) Committee. This committee will leverage local expertise to serve in an evaluative and advisory capacity around optimizing outpatient medication use. Once committee members are identified, we will host an initial kick-off meeting to further elucidate the committee’s structure and operations.
Thanks for making our clobetasol initiative successful! The network spend for clobetasol on the Excellus commercial plan decreased by 77% in 2017 compared to 2016. Recently, the price differential between clobetasol and betamethasone has narrowed, and AHP is excited to work with you on new initiatives. You will see this change reflected in your next Triple Aim Report.
ACIP now recommends Shingrix for ages 50+, and recommends Shingrix over Zostavax as the preferred vaccine to prevent herpes zoster and related complications in immunocompetent adults. More information about Shingrix below.AHP Shingrix Update January 2018